| 期 |
栏目 |
标题 |
文件 |
| 卷 80, 编号 12 (2008) |
Editorial |
Clinico-immunological disorders in patients with ischemic heart disease and metabolic syndrome: correction with nebivolol |
|
| 卷 81, 编号 2 (2009) |
Editorial |
Combined antihypertensive treatment in hypertensive patients and type 2 diabetes mellitus |
|
| 卷 81, 编号 3 (2009) |
Editorial |
Immunomodulating, metabolic and cardioprotective effects of AT1-angiotensin receptors blocker losartan in patients with coronary heart disease and type 2 diabetes mellitus |
|
| 卷 81, 编号 5 (2009) |
Editorial |
Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study |
|
| 卷 82, 编号 12 (2010) |
Editorial |
Impact of Gly389Arg 1-adrenoceptor polymorphism on the risk of chronic heart failure, the nature of its course, and on the efficiency of its treatment with carvedilol |
|
| 卷 87, 编号 4 (2015) |
Editorial |
Assessment of the role of matrix metalloproteinase-2 gene polymorphism in the development of chronic heart failure |
|
| 卷 88, 编号 9 (2016) |
Editorial |
Role of soluble Fas ligand in myocardial remodeling, severity and outcomes of chronic heart failure |
(Rus)
|
| 卷 91, 编号 1 (2019) |
Editorial |
Prognostic role of ST2 in patients with chronic heart failure of ischemic etiology and carbohydrate metabolism disorders |
(Rus)
|
| 卷 91, 编号 10 (2019) |
Editorial |
The effect of bisphosphonate therapy on reducing the risk of cardiovascular complications associated with chronic heart failure, type 2 diabetes and osteoporosis in postmenopausal women |
(Rus)
|
